Alerts

Recall of circular staplers by Ethicon due to failure to completely form staples.

Recall of Promacta (eltrombopag) 12.5 oral suspension by Novartis due to potential peanut contamination.

Recall of The Beast capsules by STIFF BOY due to undeclared sildenafil.

Recall of mycophenolate mofetil for injection by Par Pharmaceutical due to glass fragment observed in one vial of reconstituted product.

FDA issued recall of losartan potassium 25 mg, 50 mg and 100 mg tablets by Vivimed Life Sciences due to trace amounts of n-nitroso-n-methyl-4-aminobutyric acid (NMBA) impurity.

Use of certain insomnia medications has caused complex sleep behaviors resulting in serious harm or death.

FDA issued recall of ketorolac tromethamine injection by Sagent Pharmaceuticals due to lack of sterility assurance.

FDA issued recall of bevacizumab 1.25mg/0.05mL 31G injectable by AmEx Pharmacy due to reported defective delivery system.

Sudden discontinuation or rapid dose reduction of prescription opioids in patients who are physically dependent on these medications can cause serious harm including psychological distress, serious withdrawal symptoms, suicide, and...

FDA issued recall of Miller balloon atrioseptostomy catheter and Fogarty dilation atrioseptostomy catheter by Edwards Lifesciences due to balloon deflation, fragmentation and detachment Issue.

FDA issued recall of Fentanyl Transdermal System by Alvogen due to product mislabeling.

FDA issued recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP by Torrent Pharmaceuticals due to impurity.

FDA issued recall of Spine & Trauma 3D Navigation by Brainlab AG due to inaccurate display.

FDA issued recall of aphrodisiac capsules by SD Import due to undeclared sildenafil.

Prinston Pharmaceutical Inc. recalled tablets of irbesartan and irbesartan co-formulated with hydrochlorothiazide. The recall affects 1 lot of irbesartan and 7 lots of irbesartan-hydrochlorothiazide. One of the raw ingredients, irbesartan...

More manufacturers have recently recalled their valsartan products.

FDA issued recall of o_two e700, e600 and e500 automatic transport ventilators by O-Two Medical Technologies due to fire risk.

FDA issued recall of DG/Health NATURALS baby cough syrup + mucus by Kingston Pharma due to possible health risk.

FDA issued recall of BLUEFUSION capsules by Ata Int. due to undeclared ingredients.

FDA issued recall of levoleucovorin injection by Mylan Institutional due to particulate matter.

FDA issued recall of Transseptal Needle by Cook Medical due to risk of plastic fragments.

FDA issued recall of 8.4% sodium bicarbonate injection by Hospira due to particulate matter.

FDA issued recall of Losartan Potassium Tablets by Legacy Pharmaceutical Packaging due to impurity.

FDA issued a warning that tofacitinib (Xeljanz, Xeljanz XR) may increase the risk of pulmonary embolism in patients with rheumatoid arthritis.